PsiQuantum and National Cancer Center Japan Announce New Strategic Partnership to Accelerate Drug Discovery for Healthcare
PALO ALTO, Calif. – PsiQuantum announced today that the company has signed a collaborative research agreement with the National Cancer Center Japan, a leading cancer treatment and research facility, to advance applications in oncology and healthcare for utility-scale quantum computers. This new agreement underscores the enormous potential for utility-scale quantum computing across the healthcare value chain, specifically in research and development, resource allocation, and patient outcomes in cancer treatment.
PsiQuantum Collaborating with Airbus to Advance Quantum Computing for Aerospace
PsiQuantum announced today that the company is collaborating with Airbus, Europe’s largest aeronautics and space company, to advance applications in aerospace for fault-tolerant quantum computers. Under the QuLAB project at Airbus, the two companies are combining their expertise to develop and evaluate quantum algorithms for complex problems in fluid mechanics—illustrating the promise of fault-tolerant quantum computing for aerospace solutions.
PsiQuantum and Lockheed Martin Form Strategic Collaboration to Accelerate Quantum Computing for Aerospace and Defense
PsiQuantum and Lockheed Martin have signed a memorandum of understanding (MoU) to accelerate the development of quantum computing applications in aerospace and defense.
PsiQuantum Announces $10.8M Contract with Air Force Research Laboratory to Deliver Novel Quantum Chip Capabilities to the U.S. Air Force
PsiQuantum today announced a $10.8M contract with the Air Force Research Laboratory (AFRL) in Rome, N.Y., continuing a partnership that began in 2022. This phase will give AFRL a design space for comparative quantum circuits on PsiQuantum’s circuit tapeout, part of its ongoing Omega quantum chipset manufacturing with GlobalFoundries